Long Covid can affect anyone who has previously had acute COVID-19. The root causes of
this syndrome are still unknown, and no effective therapeutics are available. This complex …

Around a quarter of people who have had coronavirus disease 2019 (COVID-19)
experience symptoms that continue for at least 1 month, but one in ten are still unwell after …

Background Evidence for the impact of smoking on coronavirus disease 2019 (COVID-19) is
contradictory, and there is little research on va**. Here we provide greater clarity on …

Background Circulating testosterone levels have been found to be reduced in men with
severe acute respiratory syndrome coronavirus 2 infection, COVID‐19, with lower levels …

Outcomes following SARS-CoV-2 infection are variable; whilst the majority of patients
recover without serious complications, a subset of patients develop prolonged illness termed …

Introduction The COVID-19 pandemic has had devastating effects worldwide, but the
trajectory of the pandemic has been milder in Low-and-Middle-Income Countries (LMICs) …

The family of Suppressor of Cytokine Signalling (SOCS) proteins plays pivotal roles in
cytokine and immune regulation. Despite their key roles, little attention has been given to the …

Assessment of mucus velocity variations under different conditions including viscosity
variation and boundary conditions is useful to develop mucosal-based medical treatments …

Background: Among all studies describing COVID-19 clinical features during the first wave
of the pandemic, only a few retrospective studies have assessed the correlation between …

Objective We determined the molecular prevalence and genotype distribution of human
adenovirus (HAdV) among children under five years of age with gastroenteritis in Iran …